Longview, TX – January 12, 2025 – Gordy Roofing Longview, a long-established roofing contractor serving Longview, TX, and surrounding East Texas communities, continues to raise the bar for dependable service and quality workmanship. With decades of hands-on roofing experience, the company is widely recognized for delivering reliable residential and commercial roofing solutions designed to protect homes, …
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight’s Clinical and Developmental Analysis
“Neurofibromatosis Type 2 Pipeline” Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven by growing research momentum and increased investment in rare neurological disorders. According to DelveInsight’s latest …
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight
DelveInsight’s, “Chronic Myeloid Leukaemia Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the Chronic Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia pipeline therapeutics assessment by product type, stage, route of …
Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight
DelveInsight’s “Tendonitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover Key Insights into the Tendinopathy Market with DelveInsight’s In-Depth Report @ Tendinopathy Market …
Bipolar Disorder Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight
DelveInsight’s “Bipolar Disorder Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bipolar Disorder Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule …
Pre-Eclampsia Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
DelveInsight’s, “Pre-Eclampsia Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the …
Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outlook Through 2034, estimates DelveInsight
“Nipocalimab Market” Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren’s syndrome, Systemic lupus erythematosus and others. The Nipocalimab market is entering a pivotal growth phase, driven by recent regulatory approvals, strong late-stage clinical data, expanding geographic reach, and a robust pipeline of potential …
Myelofibrosis Market Expected to Surpass USD 5.3 Billion by 2034, estimates DelveInsight
“Myelofibrosis Market” The Myelofibrosis market across the seven major markets is projected to witness substantial expansion, growing from nearly USD 2,602 million in 2025 to about USD 5,638 million by 2034, registering a CAGR of around 9% over the forecast timeline. In 2024, the overall Myelofibrosis market was valued at approximately USD 2.2 billion, with …
Global Urinalysis Market Forecast to Surpass USD 9 Billion by 2032, estimates DelveInsight
“Urinalysis Market” Urinalysis companies include F. Hoffmann-La Roche Ltd., Beckman Coulter, Siemens Healthcare, Sysmex Corporation, Abbott, Carolina Liquid Chemistries, Medline Industries, Olive Diagnostics, ACON Laboratories, Arkray Inc., and Mindray Medical International, among others The global urinalysis market is poised for substantial expansion, with its valuation expected to almost double from USD 4,510.55 million in 2024 …
Graft Versus Host Disease Market Projected to Attain USD 3,304 Million by 2034, Estimates DelveInsight
“Graft Versus Host Disease Market” GvHD companies include Medac, MaaT Pharma, ElsaLys Biotech (Mediolanum Farmaceutici Spa), Syndax Pharmaceuticals, Kadmon Corporation, AstraZeneca, Biogen, Amgen, Pfizer, AltruBio, CSL Behring, Incyte Corporation, Takeda, OncoImmune, Merck (MSD), Regimmune Corporation, Jazz Pharmaceuticals, Millennium Pharmaceuticals, Takeda Oncology, Roche, Genentech, Bristol-Myers Squibb, Xenikos, Synthetic Biologics, Equillium/Biocon, CTI BioPharma, Novartis, GlaxoSmithKline, and others. …